A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017)

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Expert Opinion on Therapeutic Patents

• Publication date

  2017-10-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/13543776.2018.1389899PMID 29053063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The cannabinoid system and pain

  2017cited by this paper
• Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety.

  2017cited by this paper
• Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors

  2017cited by this paper
• Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's disease

  2017cited by this paper
• Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS

  2017cited by this paper
• 4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors

  2016cited by this paper
• Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.

  2016cited by this paper
• 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors

  2016cited by this paper
• Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells

  2015cited by this paper
• Inhibition of Monoacylglycerol Lipase Prevents Chronic Traumatic Encephalopathy-Like Neuropathology in a Mouse Model of Repetitive Mild Closed Head Injury

  2015cited by this paper
• Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice.

  2015cited by this paper
• Inhibition of Monoacylglycerol Lipase Prevents Chronic Traumatic Encephalopathy-like Neuropathology in a Mouse Model of Repetitive Mild Closed Head Injury

  2015cited by this paper
• Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity

  2015cited by this paper
• Identification and characterization of a new reversible MAGL inhibitor.

  2014cited by this paper
• Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy.

  2014cited by this paper
• A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis.

  2014cited by this paper
• Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain.

  2014cited by this paper
• Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1–Mediated Antinociceptive and Gastroprotective Effects

  2013cited by this paper
• Mammalian alpha beta hydrolase domain (ABHD) proteins: Lipid metabolizing enzymes at the interface of cell signaling and energy metabolism.

  2013cited by this paper
• Therapeutic potential of monoacylglycerol lipase inhibitors.

  2013cited by this paper
• Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors.

  2013cited by this paper
• Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease.

  2012cited by this paper
• Over-Expression of Monoacylglycerol Lipase (MGL) in Small Intestine Alters Endocannabinoid Levels and Whole Body Energy Balance, Resulting in Obesity

  2012cited by this paper
• A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease.

  2012cited by this paper
• Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)[S]

  2012cited by this paper
• Discovery of potent, non-carbonyl inhibitors of fatty acid amide hydrolase (FAAH)

  2012cited by this paper
• Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain

  2011cited by this paper
• Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution

  2011cited by this paper
• Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.

  2011cited by this paper
• Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer.

  2011cited by this paper
• Monoglyceride Lipase Deficiency in Mice Impairs Lipolysis and Attenuates Diet-induced Insulin Resistance*

  2011cited by this paper
• Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.

  2011cited by this paper
• Increasing endogenous 2‐arachidonoylglycerol levels counteracts colitis and related systemic inflammation

  2011cited by this paper
• Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis.

  2010cited by this paper
• A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling.

  2010cited by this paper
• The glycerophospho metabolome and its influence on amino acid homeostasis revealed by brain metabolomics of GDE1(-/-) mice.

  2010cited by this paper
• Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system

  2010cited by this paper
• A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone‐based enzyme inhibitors

  2009cited by this paper
• Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo

  2009cited by this paper
• CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

  2009cited by this paper
• Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors.

  2009cited by this paper
• Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

  2008cited by this paper
• Discovering potent and selective reversible inhibitors of enzymes in complex proteomes

  2003cited by this paper

• Chemical Probes for Investigating the Endocannabinoid System.

  2025cites this paper
• DGAT2 reduction and lipid dysregulation drive psoriasis development in keratinocyte-specific SPRY1-deficient mice

  2025cites this paper
• Neurochemical in vivo microdialysis and postmortem tissue analysis of amygdala endocannabinoid levels after MAGL- and FAAH-inhibition in rodents.

  2025cites this paper
• Highly Specific Miniaturized Fluorescent Monoacylglycerol Lipase Probes Enable Translational Research

  2025cites this paper
• A Highly Selective and Versatile Probe Platform for Visualization of Monoacylglycerol Lipase

  2025cites this paper
• Overabundant endocannabinoids in neurons are detrimental to cognitive function

  2024cites this paper
• Development of a Highly Selective NanoBRET Probe to Assess MAGL Inhibition in Live Cells

  2024cites this paper
• Promising Inhibitors of Endocannabinoid Degrading Enzymes Sharing a Carbamate Scaffold.

  2024cites this paper
• Structure-Guided Discovery of cis-Hexahydro-pyrido-oxazinones as Reversible, Drug-like Monoacylglycerol Lipase Inhibitors.

  2024cites this paper
• A carrier free delivery system of a MAGL inhibitor is effective on ovarian cancer.

  2024cites this paper
• Endocannabinoid system: An untold story in hypertensive nephropathy

  2023cites this paper
• The Metabolic Landscape of Breast Cancer and Its Therapeutic Implications

  2023cites this paper
• A Cross Talk between the Endocannabinoid System and Different Systems Involved in the Pathogenesis of Hypertensive Retinopathy

  2023influential citation
• Effect of the MAGL/FAAH Dual Inhibitor JZL-195 on Streptozotocin-Induced Alzheimer's Disease-like Sporadic Dementia in Mice with an Emphasis on Aβ, HSP-70, Neuroinflammation, and Oxidative Stress.

  2022cites this paper
• Dipeptidyl Peptidase-IV Blockers Potently Inhibit Monoglyceride Lipase: Investigation By Docking Studies And In Vitro Bioassay

  2022cites this paper
• Radiolabelling small and biomolecules for tracking and monitoring

  2022cites this paper
• Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery

  2022cites this paper
• Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain.

  2022cites this paper
• Synthesis and evaluation of carbamate derivatives as fatty acid amide hydrolase and monoacylglycerol lipase inhibitors

  2022cites this paper
• Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency

  2022cites this paper
• Effect of Monoacylglycerol Lipase Inhibition on Intestinal Permeability of Rats With Severe Acute Pancreatitis

  2022cites this paper
• Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging.

  2022cites this paper
• α/β-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related Diseases

  2021cites this paper
• Aryl N-[ω-(6-Fluoroindol-1-yl)alkyl]carbamates as Inhibitors of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and Butyrylcholinesterase: Structure–Activity Relationships and Hydrolytic Stability

  2021cites this paper
• Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl Moiety.

  2021cites this paper
• Design and Synthesis of Highly Potent and Specific ABHD6 Inhibitors

  2021cites this paper
• Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases

  2021cites this paper
• Glycerol is Released from a New Path in MGL Lipase Catalytic Process

  2021cites this paper
• The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives

  2020cites this paper
• Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications.

  2020cites this paper
• Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study

  2020cites this paper
• Patents

  2020cites this paper
• Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors.

  2020cites this paper
• Inhibitors of lipogenic enzymes as a potential therapy against cancer

  2020cites this paper
• Inhibitors of lipogenic enzymes as a potential therapy against cancer 1

  2020cites this paper
• 2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics.

  2020cites this paper
• Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model.

  2020cites this paper
• Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer

  2020cites this paper
• An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)

  2020cites this paper
• Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors

  2019cites this paper
• Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor.

  2019cites this paper
• An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability.

  2019cites this paper
• Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders

  2019influential citation
• ω-Quinazolinonylalkyl aryl ureas as reversible inhibitors of monoacylglycerol lipase.

  2019cites this paper
• Druggable Targets of the Endocannabinoid System: Implications for the Treatment of HIV-Associated Neurocognitive Disorder.

  2019cites this paper
• Novel therapies for glaucoma: a patent review (2013-2019)

  2019cites this paper
• Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder.

  2019cites this paper
• Cannabis and Cannabinoid Biology in Stroke.

  2019cites this paper
• Effect of monoacylglycerol lipase on the tumor growth in endometrial cancer

  2019cites this paper
• The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?

  2019cites this paper
• Cannabinoid interventions for PTSD: Where to next?

  2019cites this paper
• Regulation of Lipolysis in Adipose Tissue and Clinical Significance.

  2018cites this paper
• Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders

  2018cites this paper
• New approaches and challenges to targeting the endocannabinoid system

  2018cites this paper
• Pharmacological intervention of liver triacylglycerol lipolysis: The good, the bad and the ugly

  2018cites this paper
• Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington’s disease

  2018cites this paper
• Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation.

  2018cites this paper